Print Page   |   Contact Us   |   Sign In
Community Search
Featured Members

 ADVERTISEMENTS 
This section will be used for adverts.
Pharmaceutical Companies can advertise here.
Adverts will be rated and run on monthly basis.
it will be first come first served basis


BNF:
Available at the PSGH secretariat
  • British National Formulary 
    Book by Royal Pharmaceutical Society of Great Britain and British Medical Association
  • The British National Formulary is a pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about medicines.
  • PSGH CLOTH and other materials
  • Available at the PSGH Secretariat

  • News & Press: Press

    Circulating list of banned drugs is a hoax - PSGH

    Thursday, March 23, 2017   (1 Comments)
    Posted by: Frank KUMI, Editor
    Share |

    PRESS STATEMENT BY THE PHARMACEUTICAL SOCIETY OF GHANA (PSGH) ON FALSE ALLEGATIONS CIRCULATING IN SOCIAL MEDIA ON THE BAN OF CERTAIN MEDICINES.

    The attention of the Pharmaceutical Society of Ghana (PSGH) has been drawn to information circulating on some social media platforms that a list of medicines, predominantly antimalarials, have been banned for human use by the European Union and other foreign markets due to some adverse effects which have recently been associated with their use.

    The PSGH wishes to inform the public that this information is not true. Indeed, several of the medicines mentioned are legally registered in most malaria-endemic countries including Ghana. Some of these medicines, notably the artemisinin-combination therapies (ACTs), are the world’s best medicines for treating uncomplicated malaria due to Plasmodium falciparum as occurs in Ghana.

    The PSGH would like to assure the good people of Ghana that the Food and Drugs Authority (FDA) of Ghana remains the final authority on the quality, efficacy and safety of all medicines registered for use in Ghana. Both the FDA and the PSGH are happy to address any concerns on medicines in Ghana whether they are published in the media or circulating on social media. Pharmacists, as the experts on medicines, have a professional responsibility towards Ghana and Ghanaians and we take that very seriously. The PSGH further believes that the FDA’s continuous collaboration with other regulatory bodies globally boosts the FDA’s authority to address such issues if they arise anywhere in Ghana and outside the country’s borders.

    We assure Ghanaians that this nation is endowed with globally acknowledged experts in drug regulation as well as professional pharmacists who are able to deal with all category of medicines and whose training empowers them to expertly advise on medicines. These professional pharmacists are present in all the regions and most districts in Ghana to competently address any queries or suspicions. The general public is therefore advised to contact them or visit any nearby pharmacy to talk to a pharmacist when in doubt on any issue relating to the safety, quality and efficacy of medicines. The advice of pharmacists is free.The PSGH will continue to collaborate with the Ministry of Health, the FDA, the Pharmacy Council, civil society groups and the general public to provide continuous assurance about the quality of all medicines in Ghana.

    The PSGH assures the good people of Ghana that this country has a robust system and institutions for assuring the safety, quality and efficacy of medicines and affirms that medicines safety remains a key issue that the Society and its members closely monitor and are willing to provide any needed extra support, assistance and advice to Ghana.

    In conclusion, kindly ignore information circulating on social media platforms that some antimalarials have been banned for use due to some side effects. This information is false, baseless and should be duly disregarded.

    Thank you.

    Pharm. Thomas Boateng Appiagyei,
    PRESIDENT

    For further information, please contact

    PSGH

    FDA

    WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance

    Comments...

    RICHARD FIIFI BROWN-POBEE (WILLIE) says...
    Posted Sunday, March 26, 2017
    Timely